Cowan, A.J., Gras, L., Cassano, R. et al. (41 more authors) (2026) Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis. Haematologica. ISSN: 0390-6078
Abstract
The effect of different maintenance therapies on outcome after autologous hematopoietic cell transplantation (AHCT) was analyzed in newly diagnosed multiple myeloma (NDMM) patients using global real-world data. NDMM patients transplanted between 2013 and 2017 were selected from the Worldwide Network for Blood and Marrow Transplantation (WBMT) registry. Overall survival (OS) was evaluated as primary and progression-free survival (PFS), non-relapse mortality and relapse/progression incidence as secondary endpoints. Multivariable 6- month landmark analyses were performed using Cox proportional hazards models including random effect for country.
Information was available on 8,269 patients with lenalidomide (n=4,148; 50.2%), thalidomide (n=689; 8.3%) or bortezomib (n=726; 8.8%) as maintenance or no maintenance (n=2,706; 32.7%). In the 6-month landmark analysis, OS at 3 years was higher after maintenance with lenalidomide (86%), with thalidomide (80%) and with bortezomib (83%) as compared to no maintenance (79%, p<0.001) irrespective of response status at AHCT. In multivariate analyses, maintenance with lenalidomide (HR0.57, 95%CI 0.48-0.68), thalidomide (HR0.76, 95%CI 0.58-1.00) and bortezomib (HR0.65, 95%CI 0.50-0.84) were associated with better OS compared to no maintenance. Compared to no maintenance, all three medications significantly improved PFS early after HCT. The effect was gone by 30, 6, and 12 months for lenalidomide, thalidomide, and bortezomib respectively. Maintenance with lenalidomide, and to a lesser extend thalidomide and bortezomib resulted in improved OS as compared to no-maintenance in all depths of response prior to AHCT. Weaker and shorter associations were observed for PFS reflecting maintenance type, therapy discontinuation and survivor effects.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © 2026 Ferrata Storti Foundation. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0/ |
| Dates: |
|
| Institution: | The University of Sheffield |
| Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health |
| Date Deposited: | 24 Sep 2026 07:41 |
| Last Modified: | 24 Sep 2026 07:41 |
| Status: | Published online |
| Publisher: | Ferrata Storti Foundation (Haematologica) |
| Refereed: | Yes |
| Identification Number: | 10.3324/haematol.2026.301244 |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:245879 |
Download
Filename: Cowan et al Haematologica 2026.pdf
Licence: CC-BY-NC 4.0

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)